Developing stable and efficient photothermal agents (PTAs) for the second near‐infrared window (NIR‐II, 1 000–1700 nm) photothermal therapy (PTT) is highly desirable but remains challenging. Herein, a facile strategy to prepare NIR‐II nano‐PTA based on the ionic N‐doped nanographene hexapyrrolohexaazacoronene (HPHAC) is reported featuring a specific orbicular‐donor–acceptor (O‐D–A) structure. Oxidizing HPHAC 1 to dication 1 2+ causes a substantial decrease in its band gap, leading to a shift in absorption from the confined UV region to a broad absorption range that reaches up to 1400 nm. The dication 1 2+ exhibits global aromaticity and excellent stability. Theoretical investigation demonstrates that the strong NIR‐II absorption of 1 2+ is attributed to a distinct inner‐to‐outer intramolecular charge transfer. Encapsulating 1 2+ with amphiphilic polymers results in water‐soluble 1 2+ NPs with retained optical characteristics. The 1 2+ NPs exhibit exceptional biocompatibility, intense photoacoustic responses, and a high photothermal conversion efficiency of 72% under the 1064 nm laser irradiation, enabling efficient PTT of cancer cells. The “O‐D–A” system on HPHAC, which is created by a simple redox approach, provides a novel strategy to construct efficient NIR‐II photothermal materials through molecular engineering of nanographenes.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: